Coherus Oncology, Inc. (CHRS)

1.30 +0.02 (+1.56%) USD  |  NASDAQ  |  Dec 09, 13:04
More

Coherus Oncology Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for CHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
MediciNova, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade
Anavex Life Sciences Corp. --

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade